BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Lamotrigine readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Lamotrigine\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06929273-4820@assetmemo.bio
DTSTAMP:20261121T005613Z
DTSTART;VALUE=DATE:20280613
DTEND;VALUE=DATE:20280614
SUMMARY:Lamotrigine: Phase 3 readout est. (NCT06929273)
DESCRIPTION:Lamotrigine\, phase 3\, Bipolar Disorder.\nStudy: A Study to As
 sess the Long-term Safety of KarXT for the Treatment of Manic Episodes in 
 Bipolar-I Disorder (BALSAM-3)\nEstimated primary completion: 13 June 2028.
  This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, an
 d it can move.\nDrug page: https://assetmemo.bio/drug/lamotrigine#upcoming
 -events\nRegistry record: https://clinicaltrials.gov/study/NCT06929273
URL:https://assetmemo.bio/drug/lamotrigine#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
